FOX
68
-2
PFG
27
-3
TJX
64
-4
MTCH
48
11
NKE
37
-3
FSLR
63
5
NWS
52
-4
PHM
53
-4
MAC
67
2
KHC
22
2
TROW
50
2
VRSK
63
-3
FAST
46
-3
PRU
45
-2
PYPL
62
2
AAPL
64
11
EFX
60
11
NDAQ
50
-6
DVA
63
-2
KEY
31
2
FOX
68
-2
PFG
27
-3
TJX
64
-4
MTCH
48
11
NKE
37
-3
FSLR
63
5
NWS
52
-4
PHM
53
-4
MAC
67
2
KHC
22
2
TROW
50
2
VRSK
63
-3
FAST
46
-3
PRU
45
-2
PYPL
62
2
AAPL
64
11
EFX
60
11
NDAQ
50
-6
DVA
63
-2
KEY
31
2
Financhill
Back

Pacira BioSciences Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
47

PCRX
Pacira BioSciences

Last Price:
19.89
Seasonality Move:
12.01%
Sell
23

NBY
NovaBay Pharmaceuticals

Last Price:
0.58
Seasonality Move:
-6.51%
Sell
47
Pacira BioSciences (PCRX) is a Sell

Is Pacira BioSciences a Buy, Sell or Hold?

  • The current Pacira BioSciences [PCRX] share price is $19.86. The Score for PCRX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • PCRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.57. The Score for NBY is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PCRX Stock Price Chart

What is Pacira BioSciences's stock price today?

  • The Pacira BioSciences share price today is $19.86
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PCRX is experiencing buying pressure, which is a positive indicator for future bullish movement.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.57
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight buying pressure.

PCRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.83 Buy
Relative Strength Index (14 RSI): 64.1 Buy
Chaikin Money Flow: 553961 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.53 - 19.03) Buy
Bollinger Bands (100): (14.02 - 18.88) Buy

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 41.63 Sell
Chaikin Money Flow: 40319 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.57 - 0.71) Sell
Bollinger Bands (100): (0.4 - 0.86) Sell

PCRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 19.48 Buy
20-day SMA: 18 Buy
50-day SMA: 17.25 Buy
200-day SMA: 22.02 Sell
8-day EMA: 19.34 Buy
20-day EMA: 18.4 Buy
50-day EMA: 17.55 Buy
200-day EMA: 21.38 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.57 Buy
20-day SMA: 0.62 Sell
50-day SMA: 0.65 Sell
200-day SMA: 2 Sell
8-day EMA: 0.58 Sell
20-day EMA: 0.61 Sell
50-day EMA: 0.67 Sell
200-day EMA: 4.92 Sell

Pacira BioSciences Earnings Growth & PCRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.19 per share, and a decrease next year of $0.19 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Pacira BioSciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):